IMMUNEONCO-B (01541): The approval for full circulation of H shares is granted by the Hong Kong Stock Exchange for listing.
Yiming Angke-B (01541) announces, regarding the company's plan to participate in the H-share full circulation plan, the company has submitted to the Listing Committee of the Stock Exchange...
IMMUNEONCO-B(01541) announced that the company intends to participate in the H-share full circulation plan. The company has applied to the Listing Committee of the Hong Kong Stock Exchange for approval to list and trade 14,114,006 H shares on the main board of the Hong Kong Stock Exchange. The company announced that the Hong Kong Stock Exchange has granted permission to list on April 24, 2025.
Related Articles
US Stock Market Move | Federal Reserve officials blow "interest rate cut wind" three major indices rise
Giant Network Group (002558.SZ) 2024 Annual Report: Net profit increased by 31.15% year-on-year, AI innovation has been very effective.
US Stock Market Move | Trump will sign an executive order to promote the development of deep-sea mining. Odyssey Marine Exploration, Inc. (OMEX.US) surged over 90% at one point.
US Stock Market Move | Federal Reserve officials blow "interest rate cut wind" three major indices rise
Giant Network Group (002558.SZ) 2024 Annual Report: Net profit increased by 31.15% year-on-year, AI innovation has been very effective.
US Stock Market Move | Trump will sign an executive order to promote the development of deep-sea mining. Odyssey Marine Exploration, Inc. (OMEX.US) surged over 90% at one point.
RECOMMEND
Federal Reserve's Harker: Fed may cut interest rates in June if economic data is clear
24/04/2025
The big stick of tariffs cannot suppress the wave of AI-driven technology replacement. Is Apple Inc. entering a climax of stock price rebound with the "fruit chain"?
24/04/2025
Pan Gongsheng: There are no winners in a trade war or tariff war. China will continue to adhere to its policy of opening up to the outside world.
24/04/2025
